Presentation is loading. Please wait.

Presentation is loading. Please wait.

Pulmonary Resection for Lung Cancer in Patients With Idiopathic Interstitial Pneumonia  Takahiro Omori, MD, Michihiko Tajiri, MD, PhD, Tomohisa Baba, MD,

Published byScott Davidson Modified over 6 years ago

Similar presentations

Presentation on theme: "Pulmonary Resection for Lung Cancer in Patients With Idiopathic Interstitial Pneumonia  Takahiro Omori, MD, Michihiko Tajiri, MD, PhD, Tomohisa Baba, MD,"— Presentation transcript:

1 Pulmonary Resection for Lung Cancer in Patients With Idiopathic Interstitial Pneumonia 
Takahiro Omori, MD, Michihiko Tajiri, MD, PhD, Tomohisa Baba, MD, Takashi Ogura, MD, Tae Iwasawa, MD, PhD, Koji Okudela, MD, PhD, Tamiko Takemura, MD, PhD, Mari S. Oba, PhD, Takamitsu Maehara, MD, PhD, Haruhiko Nakayama, MD, PhD, Masahiro Tsuboi, MD, PhD, Munetaka Masuda, MD, PhD  The Annals of Thoracic Surgery  Volume 100, Issue 3, Pages (September 2015) DOI: /j.athoracsur Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Classifications of idiopathic interstitial pneumonia (IIP) according to the 2011 criteria (American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Latin American Thoracic Association 2011 statement) [8]. (HRCT = high-resolution computed tomography; IPF = idiopathic pulmonary fibrosis; Nonclass = nonclassifiable fibrosis; Not evaluated = IIP types not evaluated on histopathologic examination; UIP = usual interstitial pneumonia.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Overall survival curve after pulmonary resection in patients with non-small cell lung cancer according to idiopathic interstitial pneumonia status. (IPF = idiopathic pulmonary fibrosis.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

4 Fig 3 Cancer-specific survival curve after pulmonary resection in patients with non-small cell lung cancer according to idiopathic interstitial pneumonia status. (IPF = idiopathic pulmonary fibrosis.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Pulmonary Resection for Lung Cancer in Patients With Idiopathic Interstitial Pneumonia  Takahiro Omori, MD, Michihiko Tajiri, MD, PhD, Tomohisa Baba, MD,"

Similar presentations

Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E

Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E
Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L
Is lung cancer resection indicated in patients with idiopathic pulmonary fibrosis?  Atsushi Watanabe, MD, PhD, Tetsuya Higami, MD, PhD, Syunsuke Ohori,

Is lung cancer resection indicated in patients with idiopathic pulmonary fibrosis?  Atsushi Watanabe, MD, PhD, Tetsuya Higami, MD, PhD, Syunsuke Ohori,
Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease  Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.

Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease  Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.
Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer 

Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer 
History of Multiple Previous Malignancies Should Not Be a Contraindication to the Surgical Resection of Lung Cancer  Pierre-Benoit Pagès, MD, Pierre Mordant,

History of Multiple Previous Malignancies Should Not Be a Contraindication to the Surgical Resection of Lung Cancer  Pierre-Benoit Pagès, MD, Pierre Mordant,
Long-Term Survival of Patients With pN2 Lung Cancer According to the Pattern of Lymphatic Spread  Antoine Legras, MD, Pierre Mordant, MD, PhD, Alex Arame,

Long-Term Survival of Patients With pN2 Lung Cancer According to the Pattern of Lymphatic Spread  Antoine Legras, MD, Pierre Mordant, MD, PhD, Alex Arame,
Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F
Kaplan–Meier survival curves of interstitial pneumonia with autoimmune features (IPAF) with usual interstitial pneumonia (UIP) pattern (on high-resolution.

Kaplan–Meier survival curves of interstitial pneumonia with autoimmune features (IPAF) with usual interstitial pneumonia (UIP) pattern (on high-resolution.
B-Type Natriuretic Peptide as a Predictor of Postoperative Cardiopulmonary Complications in Elderly Patients Undergoing Pulmonary Resection for Lung Cancer 

B-Type Natriuretic Peptide as a Predictor of Postoperative Cardiopulmonary Complications in Elderly Patients Undergoing Pulmonary Resection for Lung Cancer 
Lobe-Specific Lymph Node Dissection as a Standard Procedure in Surgery for Non– Small Cell Lung Cancer: A Propensity Score Matching Study  Hiroyuki Adachi,

Lobe-Specific Lymph Node Dissection as a Standard Procedure in Surgery for Non– Small Cell Lung Cancer: A Propensity Score Matching Study  Hiroyuki Adachi,
Standard Uptake Value Predicts Survival in Non–Small Cell Lung Cancer

Standard Uptake Value Predicts Survival in Non–Small Cell Lung Cancer
Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer  Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.

Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer  Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Long-Term Outcomes of En Bloc Resection of Non-Small Cell Lung Cancer Invading the Thoracic Inlet and Spine  Elie Fadel, MD, Gilles Missenard, MD, Charles.

Long-Term Outcomes of En Bloc Resection of Non-Small Cell Lung Cancer Invading the Thoracic Inlet and Spine  Elie Fadel, MD, Gilles Missenard, MD, Charles.
Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes  Julie E. Bauman, MD, Michael.

Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes  Julie E. Bauman, MD, Michael.
Effect of Perioperative Pirfenidone Treatment in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis  Takekazu Iwata, MD, PhD, Shigetoshi Yoshida,

Effect of Perioperative Pirfenidone Treatment in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis  Takekazu Iwata, MD, PhD, Shigetoshi Yoshida,
Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.

Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.
Michael E. Halkos, MD, Anthony A. Gal, MD, Faraz Kerendi, MD, Daniel L

Michael E. Halkos, MD, Anthony A. Gal, MD, Faraz Kerendi, MD, Daniel L
Influence of Pulmonary Hypertension on Patients With Idiopathic Pulmonary Fibrosis Awaiting Lung Transplantation  Don Hayes, MD, MS, Sylvester M. Black,

Influence of Pulmonary Hypertension on Patients With Idiopathic Pulmonary Fibrosis Awaiting Lung Transplantation  Don Hayes, MD, MS, Sylvester M. Black,

Similar presentations

Ads by Google